|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | +9,900.00% |
|
-.--% | - |
| 12-29 | Motion for Asset Sale Approved for Seelos Therapeutics, Inc. | CI |
| 22/10/25 | GLD Partners, LP acquired Select assets from Seelos Therapeutics, Inc. (OTCPK : SEEL.Q). | CI |
Quotes 5-day view: Seelos Therapeutics, Inc.
Delayed Quote OTC Markets
| 22/07/2026 | 02/06/2026 | |
|---|---|---|
| Last | US$0.000000 | US$0.000100 |
| Volume | 3 | 380 |
| Change | - | +9,900.00% |
| Opening | US$0.000000 | US$0.000100 |
| High | US$0.000000 | US$0.000100 |
| Low | US$0.000000 | US$0.000100 |
Performance
| 1 day | +9,900.00% | ||
| 3 years | -100.00% | ||
| 5 years | -100.00% |
Volumes
marketsDaily volume
380
Estimated daily volume
3,606
Avg. Volume 20 sessions
7
Daily volume ratio
515.12
Avg. Volume 20 sessions USD
0
Record volume 1
20,969,792
Record volume 2
4,133,853
Record volume 3
1,856,218
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (USD)
136
Net sales (USD)
2
Number of employees
8
Sales / Employee ()
0
Sales / Employee (USD)
0
Free-Float
89.34 %
Free-Float capitalization (USD)
39
Average Daily Capital Traded
0%
Indicators
Moving average 100 days
0.0001
Price spread / (MMA100)
-.--%
RSI 9 days
46.19
RSI 14 days
47.15
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +9,900.00% | -.--% | -.--% | -100.00% | 136 | |
| +0.39% | +2.16% | +50.62% | +69.54% | 55.01B | |
| -1.32% | -2.71% | +34.27% | +77.57% | 54.24B | |
| +0.06% | +1.13% | -16.69% | -14.70% | 23.38B | |
| +0.60% | -2.01% | -0.48% | +373.04% | 22.57B | |
| +2.07% | +1.39% | +17.20% | -10.70% | 20.19B | |
| -1.78% | -1.73% | +28.02% | -32.62% | 17.86B | |
| -2.14% | -3.75% | +26.23% | +558.64% | 15.5B | |
| -6.69% | -5.11% | +169.13% | +304.89% | 14.2B | |
| -1.47% | +1.55% | +51.14% | +183.26% | 14.2B | |
| Average | +988.98% | -0.60% | +35.94% | +140.89% | 23.72B | |
| Weighted average by Cap. | -0.73% | -0.52% | +36.37% | +130.30% |
Historical Quotes: Seelos Therapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Course Extremes
| Current year | 0 |  | 0.01 |
| 1 year | 0 | | 0.01 |
| 3 years | 0 | | 6,374.41 |
| 5 years | 0 | | 10,713.61 |
| 10 years | 0 | | 28,761.63 |
Monthly variations
Annual variations
| 2026 | +9,900.00% | ||
| 2025 | -100.00% | ||
| 2024 | -99.87% | ||
| 2023 | -93.18% | ||
| 2022 | -58.34% | ||
| 2021 | +3.16% | ||
| 2020 | +17.91% | ||
| 2019 | -65.19% |
- Stock Market
- Stocks
- SEELQ Stock
- Quotes Seelos Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
